Page last updated: 2024-10-24

positive regulation of heme biosynthetic process

Definition

Target type: biologicalprocess

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of heme. [GOC:mah]

Positive regulation of heme biosynthesis is a complex process that ensures the proper production of heme, a vital molecule required for oxygen transport, cellular respiration, and other essential functions. It involves a series of tightly regulated enzymatic steps, each controlled by specific regulatory mechanisms to maintain heme homeostasis.

At the core of heme biosynthesis lies the enzyme **delta-aminolevulinate synthase (ALAS)**, which catalyzes the first committed step in the pathway. This enzyme is tightly regulated at the transcriptional and post-translational levels.

**Transcriptional Regulation:**

* **Erythropoietin (EPO) and other growth factors:** EPO, a hormone produced by the kidneys, stimulates the production of red blood cells, which require heme for hemoglobin synthesis. EPO upregulates ALAS expression in erythroid progenitor cells, thereby increasing heme synthesis.
* **Iron levels:** Iron is a crucial component of heme, and iron availability directly affects ALAS expression. When iron levels are high, the iron regulatory protein (IRP) binds to the iron-responsive element (IRE) in ALAS mRNA, preventing its translation. Conversely, when iron levels are low, IRP detaches from the IRE, allowing ALAS translation and heme synthesis.
* **Heme itself:** Heme acts as a negative feedback regulator, inhibiting ALAS activity at both the transcriptional and translational levels. This feedback mechanism ensures that heme production is tightly controlled and does not exceed cellular requirements.

**Post-Translational Regulation:**

* **Heme binding:** ALAS exists in two forms: an active form and an inactive form. Heme binds to the active form, inhibiting its activity and effectively shutting down heme biosynthesis.
* **Phosphorylation:** ALAS can be phosphorylated by specific kinases, which can influence its activity. However, the precise role of phosphorylation in regulating ALAS activity remains under investigation.

Beyond ALAS regulation, other factors also influence heme biosynthesis:

* **Mitochondrial localization:** Many heme biosynthesis enzymes are localized within mitochondria, the cellular powerhouses responsible for energy production. This compartmentalization is crucial for efficient heme synthesis and its integration into mitochondrial proteins.
* **Cellular differentiation:** During erythropoiesis, the process of red blood cell formation, the expression of heme biosynthesis enzymes is highly regulated, ensuring adequate heme production for hemoglobin synthesis.

The intricate interplay of these regulatory mechanisms ensures the precise control of heme biosynthesis, maintaining a delicate balance between heme production and cellular demand. This delicate balance is crucial for maintaining cellular function and preventing pathological conditions associated with heme deficiency or excess.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Sodium- and chloride-dependent glycine transporter 1A sodium- and chloride-dependent glycine transporter 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P48067]Homo sapiens (human)

Compounds (8)

CompoundDefinitionClassesRoles
glycinealpha-amino acid;
amino acid zwitterion;
proteinogenic amino acid;
serine family amino acid
EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor;
fundamental metabolite;
hepatoprotective agent;
micronutrient;
neurotransmitter;
NMDA receptor agonist;
nutraceutical
sarcosinecocobetaine: N-alkyl-betaine; cause of shampoo dermatitisN-alkylglycine;
N-alkylglycine zwitterion;
N-methyl-amino acid;
N-methylglycines
Escherichia coli metabolite;
glycine receptor agonist;
glycine transporter 1 inhibitor;
human metabolite;
mouse metabolite
hinokininhinokinin : A lignan that is dihydrofuran-2(3H)-one (gamma-butyrolactone) substituted by a 3,4-methylenedioxybenzyl group at positions 3 and 4 (the 3R,4R-diastereoisomer).

hinokinin: suppresses expression of both HBsAg and HBeAg
benzodioxoles;
gamma-lactone;
lignan
trypanocidal drug
org 24598org 24598: structure in first source
n-oleoylglycineN-oleoylglycine : A fatty acid derivative that is the 9Z-octadecenoyl derivative of glycine. It is believed to be an intermediate in oleamide biosynthesis.

oleoylglycine: long chain fatty acyl glycine
fatty amide;
N-acylglycine 18:1
metabolite
alx 5407biphenyls
alx 1393ALX 1393: a GlyT2 inhibitor
rg 1678(4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl)(5-methanesulfonyl-2-(2,2,2-trifluoro-1-methylethoxy)phenyl)methanone: a GlyT1 inhibitor; structure in first source